50419-0385 Aliqopa - CanMED: NDC

Product NDC:

50419-0385

Brand Name:

Aliqopa

Generic Name:

Copanlisib

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: Copanlisib

Strength: 15.0

Unit: mg/mL

Packages:

Code: 50419-0385-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (50419-385-01) / 4 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Sept. 14, 2017

Discontinued:

Code: 50419-0385-72

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (50419-385-72) / 4 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Oct. 30, 2018

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

PI3K

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox